Prosiectau (12573)
Cardiff University Schools involved in this Project
Targeting islet-specific CD8 Tcells in Type 1 diabetes (01.06.2015 - 31.01.2019)
- Wong, Susan
Targeting long-term responses to chemotherapy through a novel stem/immune-related vulnerability in triple negative breast cancer (23.03.2023 - 22.03.2026)
- Clarkson, Richard
Targeting NAD+ for retinal ganglion cell protection in experimental glaucoma (01.10.2019 - 30.12.2022)
- Morgan, James
Targeting natural products to counter the challenge of MRSA (01.10.2014 - 30.09.2017)
- Mcguigan, Christopher
Targeting neuroinflammation in mTORC1 driven brain tumours (01.10.2019 - 31.05.2023)
- Tee, Andrew
Targeting NF-xB activation and proliferation signals in CLL (01.11.2013 - 31.07.2018)
- Pepper, Christopher
- Targeting novel anti-complement drugs to the brain for therapy of
dementia. (01.10.2021 - 31.12.2026)- Zelek, Wioleta
Targeting of interleukin-13 receptor (IL-13R) a2 expressing pancreatic cancer by a novel hybrid lytic peptide drug (01.10.2016 - 15.11.2018)
- Brancale, Andrea
Targeting Ref1/STAT3 to treat Tuberous Sclerosis (01.04.2018 - 09.02.2023)
- Tee, Andrew
Targeting the allosteric control of alarmone synthetases to tackle bacteria persistence (01.10.2017 - 15.01.2020)
- Jin, Yi